Matinas BioPharma (MTNB) files $150M mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities climb as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts MTNB Hot Sheet
Join SI Premium – FREE
Matinas BioPharma (NYSE: MTNB) has filed $150,000,000 mixed shelf of:
Common Stock
Preferred Stock
Warrants
Debt Securities
Subscription Rights
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Aardvark Therapeutics Inc (AARD) to Perform 'We Await Visibility'
- Citius Oncology LYMPHIR wholesaler units rise 120% in Q4 2026
- One Stop Systems qualifies Gen5 expansion system for enterprise server platform
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
